Do practitioners managing mood disorders work to a sub-typing or a ‘one size fits all’ model?

Abstract

Objective:

To assess whether psychiatrists in the community operate to a sub-typing model of mood disorders when choosing psychotropic medications.

Method:

Patients assessed through the Black Dog Institute depression clinic provided information on their previously prescribed and current medications, on how effective they found them and whether they had to be ceased due to side-effects. The prevalence of each medication trialled was analysed according to diagnosis (bipolar I, bipolar II, unipolar melancholic depression or unipolar non-melancholic depression).

Results:

Analyses indicate that psychiatrists prescribe medications differentially in line with diagnosis. This effect was found in both previously prescribed and currently prescribed medications, and was most distinct for mood stabiliser and antipsychotic medications. Several medications, in contrast, appeared to have been trialled by the majority of patients, regardless of diagnosis. Analyses of effectiveness and cessation due to side-effects were compromised by small sub-sample sizes.

Conclusions:

Psychiatrists in the community appear to operate to a sub-typing model of mood disorders, preferentially prescribing many medications according to mood disorder sub-type.

Keywords

bipolar depression diagnosis medication mood disorder

Get full access to this article

View all access options for this article.

References

Parker

Manicavasagar

. Modelling and managing the depressive disorders: A clinical guide. Cambridge: Cambridge University Press, 2005.

Parker

Mitchell

Wilhelm

. Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review. Aust New Zeal J Psychiatr 1999; 33(6): 874–881.

Parker

Roy

Wilhelm

. Assessing the comparative effectiveness of antidepressant therapies: A prospective clinical practice study. J Clin Psychiatr 2001; 62(2): 117–125.

Parker

. Bipolar II disorder: Modelling, measuring and managing. Cambridge: Cambridge University Press, 2012.

Fountoulakis

Vieta

. Treatment of bipolar disorder: A systematic review of available data and clinical perspectives. Int J Neuropsychopharmacol 2008; 11(07): 999–1029.

Parker

Fletcher

Hyett

. The Mood Assessment Program: A computerised diagnostic tool for deriving management plans for mood disorders. Med J Aust 2008; 188(12): S126–S128.

Sheehan

Janavs

Baker

. MINI – Mini International Neuropsychiatric Interview – English Version 5.0.0 – DSM-IV. J Clin Psychiatr 1998; 59: 34–57.

American Psychological Association. Diagnostic and statistical manual of mental disorders, fourth edition: DSM-IV-TR®. Arlington: American Psychiatric Association, 2000.

Roose

Glassman

Attia

. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatr 1994; 151(12): 1735–1739.

10.

Perry

. Pharmacotherapy for major depression with melancholic features: Relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord 1996; 39(1): 1–6.